Barclays analyst Alex Scott lowered the firm’s price target on Corebridge (CRBG) to $33 from $34 and keeps an Overweight rating on the shares. The firm adjusted targets in the life insurance group after revisiting cash flow and private credit exposures to separate “perceived from actual risk.”
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
